Search Within

Radiology, Department of

  1. "Department of Medicine"
Formats
  1. Journal Article (1371)
  2. Meeting Abstract (901)
  3. Review (30)
  4. Book Section (14)
  5. Conference Paper (14)
  6. Guidelines (10)
  7. Research Letter (9)
  8. Correspondence (5)
  9. Editorial (4)
  10. Miscellaneous (2)
Groups
  1. Department of Medicine (2360)
  2. Solid Tumor Oncology Division (1733)
  3. GSK Faculty (1140)
  4. Body Imaging Service (987)
  5. Molecular Imaging and Therapy Service (941)
  6. Epidemiology and Biostatistics (813)

More Groups

People
  1. Steven Larson (385)
  2. Heiko Schoder (266)
  3. Howard Scher (178)
  4. Michael Morris (161)
  5. David Scheinberg (151)
  6. Michelle Ginsberg (151)

More People

Years
  1. 2025 (31)
  2. 2024 (132)
  3. 2023 (135)
  4. 2022 (144)
  5. 2021 (127)
  6. 2020 (158)

More Years

Publications
  1. Journal of Clinical Oncology (484)
  2. Journal of Nuclear Medicine (171)
  3. Blood (112)
  4. Clinical Cancer Research (107)
  5. Cancer Research (81)
  6. International Journal of Radiation Oncology, Biology, Physics (57)

More Publications

Publishers
  1. American Society of Clinical Oncology (508)
  2. American Association for Cancer Research (231)
  3. Elsevier Inc. (221)
  4. Society of Nuclear Medicine (171)
  5. Springer (164)
  6. American Society of Hematology (118)

More Publishers

Results (2360)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • PET imaging of [(18)F]PARP inhibitor as a pharmacodynamic biomarker of talazoparib in small cell lung cancer PDXs
    Meeting Abstract

    Lok, B.; Laird, J.; Carney, B.; Kossatz, S.; De Stanchina, E.; Reiner, T.; Poirier, J.; Rudin, C.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Multifactorial model to predict response to PD-(L)1 blockade in patients with high PD-L1 metastatic non-small cell lung cancer
    Meeting Abstract

    Arbour, K.; Oprescu, M.; Hakim, J.; Rizvi, H.; Leiserson, M.; Ginsburg, M.; Plodkowski, A.; Sauter, J.; Preeshagul, I.; Gillett, S.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Phase II study of enzalutamide in androgen receptor positive (AR+) recurrent ovarian cancer: Final results
    Meeting Abstract

    Grisham, R.; Giri, D.; Henson, M.; Iasonos, A.; Zhou, Q.; McDonnell, A.; Girshman, J.; O'Cearbhaill, R.; Zamarin, D.; Aghajanian, C.
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save
  • Baseline FDG-PET/CT detects bone marrow involvement in follicular lymphoma and provides relevant prognostic information
    Meeting Abstract

    Nakajima, R.; Moskowitz, A. J.; Michaud, L.; Mauguen, A.; Schòˆder, H.
    European Journal of Nuclear Medicine and Molecular Imaging (2019)

    Fulltext@MSK | Save
  • Synthesis, preclinical analysis, and first-in-human phase I imaging of 89Zr-DFO-daratumumab for CD38 targeted imaging of myeloma
    Meeting Abstract

    Ulaner, G.; Sobol, N.; O'Donoghue, J.; Lyashchenko, S.; Lewis, J.; Landgren, C. O.
    Clinical Lymphoma, Myeloma and Leukemia (2019)

    Fulltext@MSK | Save
  • A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy
    Meeting Abstract

    McArthur, H. L.; Comen, E. A.; Bryce, Y.; Solomon, S. B.; Leal, J. H. S.; Rodine, M.; Abaya, C. D.; Patil, S.; Page, D. B.; Norton, L.
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
    Meeting Abstract

    Janjigian, Y. Y.; Maron, S.; Chou, J. F.; Gabler, A. R.; Simmons, M. Z.; Momtaz, P.; Shcherba, M.; Ku, G. Y.; Won, E.; Sanchez-Vega, F.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Imaging patients with metastatic castration-resistant prostate cancer using (89)Zr-DFO-MSTP2109A anti-STEAP1 antibody
    Journal Article

    Carrasquillo, J. A.; Fine, B. M.; Pandit-Taskar, N.; Larson, S. M.; Fleming, S. E.; Fox, J. J.; Cheal, S. M.; O'Donoghue, J. A.; Ruan, S.; Ragupathi, G.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • EGFR mutation subtypes and response to immune checkpoint blockade treatment in non-small-cell lung cancer
    Journal Article

    Hastings, K.; Yu, H. A.; Wei, W.; Sanchez-Vega, F.; DeVeaux, M.; Choi, J.; Rizvi, H.; Lisberg, A.; Truini, A.; Lydon, C. A.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Measuring the unmeasurable: Automated bone scan index as a quantitative endpoint in prostate cancer clinical trials
    Review

    Mota, J. M.; Armstrong, A. J.; Larson, S. M.; Fox, J. J.; Morris, M. J.
    Prostate Cancer and Prostatic Diseases (2019)

    Fulltext@MSK | Save